STERIS plc
For the period ended Mar 31, 2024. Filed May 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 29, 2024
STE$257.12+0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Years Ended March 31, | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating activities: | |||
| Net income | $380,079 | $105,813 | $242,870 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, depletion, and amortization | 565,244 | 552,897 | 553,104 |
| Deferred income taxes | (131,412) | (185,913) | (106,620) |
| Share-based compensation expense | 56,535 | 38,951 | 57,660 |
| Loss on the disposal of property, plant, equipment, and intangibles, net | 24,997 | 22,193 | 15,117 |
| Loss on classification as held for sale | 206,444 | — | — |
| Loss (gain) on sale of businesses | 873 | (67) | (874) |
| Gain on sale of investments | (546) | — | — |
| Fair value adjustment related to convertible debt, premium liability | — | — | 27,806 |
| Amortization of inventory fair value adjustments | 4,822 | 7,363 | 66,663 |
| Goodwill impairment loss | — | 490,565 | — |
| Other items | 12,316 | (24,832) | (21,639) |
| Changes in operating assets and liabilities, net of effects of acquisitions: | |||
| Accounts receivable, net | (128,069) | (133,304) | (51,969) |
| Inventories, net | (37,450) | (123,921) | (102,922) |
| Other current assets | (1,552) | (24,086) | 7,126 |
| Accounts payable | (18,962) | 53,342 | 14,887 |
| Accruals and other, net | 39,955 | (22,054) | (16,398) |
| Net cash provided by operating activities | 973,274 | 756,947 | 684,811 |
| Investing activities: | |||
| Purchases of property, plant, equipment, and intangibles, net | (360,326) | (361,969) | (287,563) |
| Proceeds from the sale of property, plant, equipment, and intangibles | 7,381 | 14,587 | 1,741 |
| Proceeds from the sale of businesses | 9,458 | 6,624 | 169,712 |
| Proceeds from the sale of investments | 3,882 | — | — |
| Investment in convertible notes | (1,500) | — | — |
| Acquisition of businesses, net of cash acquired | (546,256) | (42,572) | (550,449) |
| Net cash used in investing activities | (887,361) | (383,330) | (666,559) |
| Financing activities: | |||
| Proceeds from issuance of senior public notes | — | — | 1,350,000 |
| Proceeds from term loans | — | — | 650,000 |
| Payments on term loans | (60,000) | (156,875) | (345,000) |
| Payments on Private Placement Senior Notes | — | (91,000) | (721,284) |
| Payments on convertible debt | — | — | (371,361) |
| Proceeds (payments) under credit facilities, net | 181,486 | 241,657 | (190,174) |
| Deferred financing fees and debt issuance costs | — | — | (17,472) |
| Acquisition related deferred or contingent consideration | (6,242) | (1,471) | (32,679) |
| Repurchases of ordinary shares | (11,765) | (308,565) | (55,777) |
| Cash dividends paid to ordinary shareholders | (200,570) | (183,498) | (163,169) |
| Distributions to noncontrolling interest holders | (1,561) | (794) | (997) |
| Contributions from noncontrolling interest holders | 2,994 | — | 3,672 |
| Stock option and other equity transactions, net | 10,472 | 1,828 | 10,071 |
| Net cash (used in) provided by financing activities | (85,186) | (498,718) | 115,830 |
| Effect of exchange rate changes on cash and cash equivalents | (2,064) | (14,862) | (6,293) |
| (Decrease) increase in cash and cash equivalents | (1,337) | (139,963) | 127,789 |
| Cash and cash equivalents at beginning of period | 208,357 | 348,320 | 220,531 |
| Cash and cash equivalents at end of period | $207,020 | $208,357 | $348,320 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.